The new, clearer design is intended to allow readers to customise http://www.in-PharmaTechnologist.com to show one of four microsites: Ingredients, Processing, Drug Delivery, and Regulatory & Safety.
Key Features of the refreshed site include four microsites for the delivery of targeted news in key biopharma manufacturing niches; clearer, more intuitive design and navigation system to simplify reading and searching; deeper global coverage of all corners of the biopharma world; increased focus on in-depth analysis of a complex, evolving industry; and continued innovation in delivering news in the medium customers want, to the platform they use.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia